Focused Ultrasound For Tissue Heat Or Mechanical Cellular Disruption
FDA product code OHV · 26 cleared devices
Class 2
General, Plastic Surgery
- Regulation
- 21 CFR 878.4590
- Review panel
- SU
- Implant
- No
- Life sustaining
- No
- Third party review
- No
- GMP exempt
- No
- Clearance span
- 2011-08-19 – 2026-05-21
A device using focused ultrasound to produce localized, mechanical motion within tissues and cells for the purpose of producing either localized heating for tissue coagulation or for mechanical cellular membrane disruption intended for non-invasive aesthetic use.
OHV
2026-05-21
OHV
2025-05-13
Ulthera System (UC-1 Control Unit PRIME Model 2.1)
View details →
OHV
2025-02-24
Ulthera® System
View details →
OHV
2024-05-30
SofWave System
View details →
OHV
2024-02-22
Ulthera System (UC-1 Control Unit PRIME)
View details →
OHV
2023-12-22
SofWave System
View details →
OHV
2023-12-14
SofWave System
View details →
OHV
2023-11-03
SCIZER (SC1-M410)
View details →
OHV
2023-09-29
BeShape One™ Device
View details →
OHV
2023-08-28
SofWave System
View details →
OHV
2023-04-18
SofWave System
View details →
OHV
2023-03-14
SofWave System
View details →
OHV
2022-12-16
SofWave System
View details →
OHV
2021-11-15
SofWave System
View details →
OHV
2019-10-18
LIPOcel
View details →
OHV
2019-09-09
Sofacia System
View details →
OHV
2018-05-04
Ulthera System
View details →
OHV
2017-05-15
ULTRASHAPE POWER SYSTEM
View details →
OHV
2016-11-17
UltraShape System
View details →
OHV
2016-11-07
UltraShape System
View details →
OHV
2016-07-08
ULTRASHAPE POWER SYSTEM
View details →
OHV
2013-12-11
ULTHERA SYSTEM
View details →
OHV
2012-10-02
ULTHERA SYSTEM
View details →
OHV
2012-08-28
ULTHERA SYSTEM
View details →
OHV
2011-10-20
LIPSONIX(R) SYSTEM MODEL 2
View details →
OHV
2011-08-19
LIPOSONIX SYSTEM, MODEL 1 P00XXXX
View details →No matching devices.
Advertisement